Status:
COMPLETED
This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke
Lead Sponsor:
Boehringer Ingelheim
Collaborating Sponsors:
Karolinska University Hospital
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
This is an observational study in patients with non-valvular atrial fibrillation (NVAF) presenting to the hospital with a first acute ischemic stroke based on existing data recorded in the SITS Intern...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Patients with non-valvular Atrial Fibrillation (NVAF)
- Patients presenting with their first acute ischemic stroke
- ≥18 years of age
- Exclusion criteria:
- \- Documentation that the patient was enrolled or is planned to be enrolled in an investigational clinical trial at the time of the onset of the index event and for the duration of the data collection
Exclusion
Key Trial Info
Start Date :
November 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 17 2019
Estimated Enrollment :
1489 Patients enrolled
Trial Details
Trial ID
NCT03258645
Start Date
November 15 2018
End Date
June 17 2019
Last Update
July 9 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SITS International (c/o Karolinska University Hospital)
Stockholm, Sweden, 171 76